Prevention of recurrence after liver transplantation for hepatocellular carcinoma

  • Henri Bismuth
  • René Adam
  • Denis Castaing
  • Laurence Chiche
  • Joseph S. Raccuia
Part of the Transplantation and Clinical Immunology book series (TRAC, volume 27)


Hepatocellular carcinoma (HCC) when left untreated has an extremely poor prognosis. Liver transplantation in certain situations has proven benefit despite a high incidence of recurrence, although, survival at 5 years, is still the lowest compared to other indications for transplantation. We have, since our initial retrospective report [1], carefully selected patients with a chance for cure based upon the size and number of lesions. Subsequently, in this second prospective period, the results of this new approach were reviewed with emphasis on evaluating factors of recurrence and survival for patients with known HCC in cirrhosis.


Hepatocellular Carcinoma Liver Transplantation Liver Resection Primary Biliary Cirrhosis Primary Sclerosing Cholangitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bismuth H, Chiche L, Adam R, et al.: Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218: 145–151.PubMedCrossRefGoogle Scholar
  2. 2.
    Colombo M: Hepatocellular carcinoma. J Hepatol 1992; 15: 225–236.PubMedCrossRefGoogle Scholar
  3. 3.
    Carr BI: An assay for micrometastatic hepatocellular carcinoma. Gastroenterology. 1994; 106: 264–267.PubMedGoogle Scholar
  4. 4.
    Iwatzuki S, Starzl TE, Sheahan DG, et al.: Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214: 221–229.CrossRefGoogle Scholar
  5. 5.
    Ismail T, Angrisani L, Gunson BK, et al.: Primary hepatic malignancy: The role of liver transplantation. Br J Surg 1990; 77: 983–987.PubMedCrossRefGoogle Scholar
  6. 6.
    O’Grady, JG, Polsen RJ, Rolles K, et al.: Liver transplantation for malignant disease: Results in 93 consecutive patients. Ann Surg, 1988; 207: 373–379; Cancer therapy. Ann Surg 1985; 202: 401–07.PubMedCrossRefGoogle Scholar
  7. 7.
    Bismuth H, Morino M, Sherlock DG, et al.: Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Ann Surg 1992; 163: 387–394.CrossRefGoogle Scholar
  8. 8.
    Matsumura M, Nima Y, Kato N, et al.: Detection of alfafetoprotein mRNA, as an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: A possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994; 20: 1418–1425.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Henri Bismuth
  • René Adam
  • Denis Castaing
  • Laurence Chiche
  • Joseph S. Raccuia

There are no affiliations available

Personalised recommendations